Loading organizations...
§ Venture Capital · 28025 Dorothy Dr. Agoura Hills, CA 91301
Tri-State Growth Fund operates as a strategic investment vehicle, channeling capital into early-stage companies, primarily through mechanisms like convertible notes and growth grants. The fund's approach focuses on supporting the development and scaling of fledgling businesses, providing essential financing to accelerate innovation and foster economic expansion within its targeted geographic regions. Its investment strategy emphasizes direct support for entrepreneurs aiming to transition nascent ideas into viable commercial enterprises.
The fund's inception, particularly in the venture capital landscape, is closely linked to collaborations with regional ecosystem builders and leveraging public-private initiatives. Key figures in its formation include individuals like Richard Kiley, who contributed to establishing the fund alongside organizations such as CincyTech USA. This foundational effort aimed to create a dedicated funding source for promising ventures, often in partnership with other regional investment groups like Queen City Angels, catalyzing local entrepreneurial activity.
Tri-State Growth Fund serves a diverse portfolio of early-stage companies and entrepreneurs, providing the critical capital necessary for their expansion. Its long-term vision centers on cultivating a robust and dynamic regional economy by identifying and investing in high-potential businesses. By empowering these emerging companies, the fund seeks to drive sustainable growth, generate local value, and solidify the region's position as a hub for innovation and business development.
Tri-State Growth Fund has 1 tracked investment across 1 company. The latest tracked deal is $22.2M Series B in Juventas Therapeutics in July 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 16, 2012 | Juventas Therapeutics | $22.2M Series B | Triathlon Medical Ventures | Early Stage Partners, Fletcher Spaght Ventures, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Venture Investors |